Search Results 3451-3460 of 37260 for oral
... Oral lichen planus, Nonmelanoma skin cancer, Tuberous sclerosis, Klippel-Trenaunay syndrome, Melasma, Alopecia areata, Diffuse capillary malformation with ...
The purpose of the InformCLL Registry is to characterize and describe treatment patterns for those initiating treatment with approved oral kinase inhibitors ...
... Oral and throat cancer, Laryngeal cancer, Skull base tumor, Oropharyngeal cancer. Show more areas of focus for Daniel J. Ma, M.D. ...
... oral; contraceptives, hormones, gonadotropin releasing hormone, antiestrogens, selective estrogen receptor modulators [SERMs], or chemotherapy);; spontaneous ...
Antibiotic regimen (for the most recent CDI episode) should be14 days of oral vancomycin (125 mg, q6h) or 10 days of oral fidaxomicin (200 mg, q12h) with ...
... Oral biopsy, Microvascular surgery, Skull base surgery, Skin cancer reconstruction, Submandibular gland removal, Radial forearm free flap, Oral cancer ...
* Treatment with systemic corticosteroid use within 8 weeks (oral) ... * For female participants on ethinyl oestradiol containing combined oral contraceptives.
This phase II trial gathers information on the feasibility, safety, and effect of giving methotrexate, erlotinib, and celecoxib in treating oral cavity ...
cardiovascular disease, premature birth and low birth weight, rheumatoid arthritis, and eating disorders. Learn more about why paying attention to oral health ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!